Pune, India

Rajiv Kumar Shakya

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Lupin, Inc.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rajiv Kumar Shakya. Retrieved from https://idiyas.com/inventor/rajiv-kumar-shakya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rajiv Kumar Shakya: Innovator in Pharmaceutical Chemistry

Introduction

Rajiv Kumar Shakya is a notable inventor based in Pune, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of novel compounds. His work has implications for the development of new medications and therapeutic agents.

Latest Patents

Rajiv Kumar Shakya holds a patent for "Intermediates in the preparation of 1,4-diphenyl azetidinone." This patent describes a method for synthesizing a 1,4-diphenylazetidinone of formula (VIII) using novel oxime intermediates. This innovative approach enhances the efficiency and effectiveness of the synthesis process.

Career Highlights

Rajiv is currently employed at Lupin, Inc., a leading global pharmaceutical company. His role involves research and development, where he applies his expertise in chemistry to create new pharmaceutical products. His dedication to innovation has positioned him as a valuable asset to his team and the industry.

Collaborations

Rajiv has collaborated with several talented professionals, including Dhananjai Srivastava and Namrata Anil Chaudhari. These collaborations have fostered a creative environment that encourages the exchange of ideas and advancements in their respective fields.

Conclusion

Rajiv Kumar Shakya's contributions to pharmaceutical chemistry through his innovative patent and collaborative efforts highlight his importance in the industry. His work continues to pave the way for advancements in medication development and synthesis techniques.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…